Efficacy and Safety of Intranasal Betahistine in the Treatment of Surgery-Induced Acute Vestibular Syndrome: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Study.

Otol Neurotol · 2023 · PMC10184813 · PMID 37026797

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The VRBQ showed a trend for superior improvement for the AM-125 20-mg group over the placebo group at all study visits (1.2–3.8 percentage points), primarily driven by ameliorations in the dizziness and quality of life subscales.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.